These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31035469)

  • 1. Effects of a Novel Nutraceutical Combination (Aquilea Colesterol
    Domenech M; Casas R; Ruiz-León AM; Sobrino J; Ros E; Estruch R
    Nutrients; 2019 Apr; 11(5):. PubMed ID: 31035469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized, Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO
    Cicero AFG; D'Addato S; Borghi C
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33066334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia.
    Protic O; Di Pillo R; Montesanto A; Galeazzi R; Matacchione G; Giuliani A; Sabbatinelli J; Gurău F; Silvestrini A; Olivieri F; Antonicelli R; Bonfigli AR
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.
    Ruscica M; Pavanello C; Gandini S; Macchi C; Botta M; Dall'Orto D; Del Puppo M; Bertolotti M; Bosisio R; Mombelli G; Sirtori CR; Calabresi L; Magni P
    Nutr J; 2019 Feb; 18(1):13. PubMed ID: 30795775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial.
    Cicero AF; Colletti A; Fogacci F; Bove M; Rosticci M; Borghi C
    High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):13-18. PubMed ID: 27339779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.
    Cicero AF; Derosa G; Pisciotta L; Barbagallo C;
    J Med Food; 2015 Nov; 18(11):1270-3. PubMed ID: 26274827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a novel nutraceutical combination (BruMeChol™) in subjects with mild hypercholesterolemia: study protocol of a randomized, double-blind, controlled trial.
    Bonfigli AR; Protic O; Olivieri F; Montesanto A; Malatesta G; Di Pillo R; Antonicelli R
    Trials; 2020 Jul; 21(1):616. PubMed ID: 32631422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on oral fat load of a nutraceutical combination of fermented red rice, sterol esters and stanols, curcumin, and olive polyphenols: A randomized, placebo controlled trial.
    Derosa G; Catena G; Raddino R; Gaudio G; Maggi A; D'Angelo A; Maffioli P
    Phytomedicine; 2018 Mar; 42():75-82. PubMed ID: 29655700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial.
    Cicero AFG; Fogacci F; Bove M; Veronesi M; Rizzo M; Giovannini M; Borghi C
    Adv Ther; 2017 Aug; 34(8):1966-1975. PubMed ID: 28687937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A softgel dietary supplement containing esterified plant sterols and stanols improves the blood lipid profile of adults with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled replication study.
    McKenney JM; Jenks BH; Shneyvas E; Brooks JR; Shenoy SF; Cook CM; Maki KC
    J Acad Nutr Diet; 2014 Feb; 114(2):244-249. PubMed ID: 24287284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a Combination of Berberis aristata, Silybum marianum and Monacolin on Lipid Profile in Subjects at Low Cardiovascular Risk; A Double-Blind, Randomized, Placebo-Controlled Trial.
    Derosa G; D'Angelo A; Romano D; Maffioli P
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28178209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (
    Cicolari S; Pavanello C; Olmastroni E; Puppo MD; Bertolotti M; Mombelli G; Catapano AL; Calabresi L; Magni P
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33525601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and Safety of Dietetic Supplementation of a New Nutraceutical on Lipid Profile and Serum Inflammation Biomarkers in Hypercholesterolemic Patients.
    Riccioni G; Gammone MA; Currenti W; D'Orazio N
    Molecules; 2018 May; 23(5):. PubMed ID: 29757945
    [No Abstract]   [Full Text] [Related]  

  • 14. Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects.
    Cicero AF; Derosa G; Parini A; Maffioli P; D'Addato S; Reggi A; Giovannini M; Borghi C
    Nutr Res; 2013 Aug; 33(8):622-8. PubMed ID: 23890351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NUtraceutical TReatment for hYpercholesterolemia in HIV-infected patients: The NU-TRY(HIV) randomized cross-over trial.
    Pirro M; Francisci D; Bianconi V; Schiaroli E; Mannarino MR; Barsotti F; Spinozzi A; Bagaglia F; Sahebkar A; Baldelli F
    Atherosclerosis; 2019 Jan; 280():51-57. PubMed ID: 30471555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, placebo-controlled study on the effects of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters.
    Derosa G; Bonaventura A; Bianchi L; Romano D; D'Angelo A; Fogari E; Maffioli P
    J Biol Regul Homeost Agents; 2014; 28(2):317-24. PubMed ID: 25001663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single blind, multicentre, randomized, controlled trial testing the effects of a novel nutraceutical compound on plasma lipid and cardiovascular risk factors: Results of the interim analysis.
    Trimarco V; Battistoni A; Tocci G; Coluccia R; Manzi MV; Izzo R; Volpe M
    Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):850-857. PubMed ID: 28965797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia.
    Magno S; Ceccarini G; Pelosini C; Jaccheri R; Vitti J; Fierabracci P; Salvetti G; Airoldi G; Minale M; Saponati G; Santini F
    Lipids Health Dis; 2018 May; 17(1):124. PubMed ID: 29793488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta-analysis of randomized controlled trials.
    Pirro M; Mannarino MR; Bianconi V; Simental-Mendía LE; Bagaglia F; Mannarino E; Sahebkar A
    Pharmacol Res; 2016 Aug; 110():76-88. PubMed ID: 27157250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of a nutraceutical combination of red yeast rice, guggulipid, and chromium picolinate evaluated in a randomized, placebo-controlled, double-blind study.
    Iskandar I; Harahap Y; Wijayanti TR; Sandra M; Prasaja B; Cahyaningsih P
    Complement Ther Med; 2020 Jan; 48():102282. PubMed ID: 31987238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.